These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21062428)

  • 1. Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial.
    Combs SE; Edler L; Burkholder I; Rieken S; Habermehl D; Jäkel O; Haberer T; Unterberg A; Wick W; Debus J; Haselmann R
    BMC Cancer; 2010 Nov; 10():615. PubMed ID: 21062428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
    Combs SE; Burkholder I; Edler L; Rieken S; Habermehl D; Jäkel O; Haberer T; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Oct; 10():533. PubMed ID: 20925951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial.
    Deng MY; Maas SLN; Hinz F; Karger CP; Sievers P; Eichkorn T; Meixner E; Hoegen-Sassmannshausen P; Hörner-Rieber J; Lischalk JW; Seidensaal K; Bernhardt D; Jungk C; Unterberg A; Wick A; Wick W; von Deimling A; Sahm F; Combs S; Herfarth K; Debus J; König L
    Neuro Oncol; 2024 Apr; 26(4):701-712. PubMed ID: 38079455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
    Combs SE; Kieser M; Rieken S; Habermehl D; Jäkel O; Haberer T; Nikoghosyan A; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Sep; 10():478. PubMed ID: 20819220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial.
    Combs SE; Kieser M; Habermehl D; Weitz J; Jäger D; Fossati P; Orrechia R; Engenhart-Cabillic R; Pötter R; Dosanjh M; Jäkel O; Büchler MW; Debus J
    BMC Cancer; 2012 Apr; 12():137. PubMed ID: 22472035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial.
    Combs SE; Habermehl D; Ganten T; Schmidt J; Edler L; Burkholder I; Jäkel O; Haberer T; Debus J
    BMC Cancer; 2011 Feb; 11():67. PubMed ID: 21314962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.
    Combs SE; Habermehl D; Kieser M; Dreher C; Werner J; Haselmann R; Jäkel O; Jäger D; Büchler MW; Debus J
    BMC Cancer; 2013 Sep; 13():419. PubMed ID: 24034562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts.
    Rieken S; Habermehl D; Haberer T; Jaekel O; Debus J; Combs SE
    Radiat Oncol; 2012 Mar; 7():41. PubMed ID: 22436135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
    Wu A; Jin MC; Meola A; Wong HN; Chang SD
    Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
    Blattmann C; Oertel S; Schulz-Ertner D; Rieken S; Haufe S; Ewerbeck V; Unterberg A; Karapanagiotou-Schenkel I; Combs SE; Nikoghosyan A; Bischof M; Jäkel O; Huber P; Kulozik AE; Debus J
    BMC Cancer; 2010 Mar; 10():96. PubMed ID: 20226028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
    Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon ion radiation therapy for high-risk meningiomas.
    Combs SE; Hartmann C; Nikoghosyan A; Jäkel O; Karger CP; Haberer T; von Deimling A; Münter MW; Huber PE; Debus J; Schulz-Ertner D
    Radiother Oncol; 2010 Apr; 95(1):54-9. PubMed ID: 20189258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
    Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
    J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial.
    Brügemann D; Lehner B; Kieser M; Krisam J; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Sedlaczek O; Egerer G; Geisbüsch A; Uhl M; Debus J; Seidensaal K
    BMC Cancer; 2022 May; 22(1):538. PubMed ID: 35550036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy.
    Wenkel E; Thornton AF; Finkelstein D; Adams J; Lyons S; De La Monte S; Ojeman RG; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1363-70. PubMed ID: 11121635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.
    Balosso J; Febvey-Combes O; Iung A; Lozano H; Alloh AS; Cornu C; Hervé M; Akkal Z; Lièvre M; Plattner V; Valvo F; Bono C; Fiore MR; Vitolo V; Vischioni B; Patin S; Allemand H; Gueyffier F; Margier J; Guerre P; Chabaud S; Orecchia R; Pommier P
    BMC Cancer; 2022 May; 22(1):575. PubMed ID: 35606739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution.
    Pisćević I; Villa A; Milićević M; Ilić R; Nikitović M; Cavallo LM; Grujičić D
    World Neurosurg; 2015 Jun; 83(6):987-95. PubMed ID: 25769488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review of Ion Radiotherapy in Maintaining Local Control Regarding Atypical and Anaplastic Meningiomas.
    Coggins WS; Pham NK; Nguyen AV; Branch DW; Guillet JY; Korst G; Lall RR
    World Neurosurg; 2019 Dec; 132():282-291. PubMed ID: 31476452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric response of intracranial meningioma after photon or particle irradiation.
    Mozes P; Dittmar JO; Habermehl D; Tonndorf-Martini E; Hideghety K; Dittmar A; Debus J; Combs SE
    Acta Oncol; 2017 Mar; 56(3):431-437. PubMed ID: 27911139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
    Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
    Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.